Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aminocaproate trough measurement |
Has measured component |
False |
Aminocaproic acid |
Inferred relationship |
Some |
|
Accidental aminocaproic acid poisoning |
Causative agent |
False |
Aminocaproic acid |
Inferred relationship |
Some |
|
Intentional aminocaproic acid poisoning (disorder) |
Causative agent |
False |
Aminocaproic acid |
Inferred relationship |
Some |
|
forgiftning med aminocapronsyre, uvist med hvilken hensigt |
Causative agent |
False |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Poisoning by aminocaproic acid |
Causative agent |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproate trough measurement |
Component |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Product containing aminocaproic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminocaproic acid |
Inferred relationship |
Some |
|
aminocapronsyre 250 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminocaproic acid |
Inferred relationship |
Some |
|
aminocapronsyre 1,25 g/5 ml oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminocaproic acid |
Inferred relationship |
Some |
|
Accidental aminocaproic acid poisoning |
Causative agent |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Intentional aminocaproic acid poisoning (disorder) |
Causative agent |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Product containing aminocaproic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Product containing only aminocaproic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Product containing only aminocaproic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid 250 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |
Aminocaproic acid 250 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aminocaproic acid |
Inferred relationship |
Some |
1 |